Sumai Medical Completes Nearly RMB 100 Million Pre-IPO Round and Passes IPO Counseling Inspection

Recently, the official website of the CSRC showed that Zumax Medical Co., Ltd. (hereinafter referred to as "Zumax") completed the IPO coaching inspection. The coaching institution was HAITONG Securities Company Limited, and the dispatched institution was Jiangsu Regulatory Bureau of the CSRC.

Source of the image: Official website of the CSRC

According to the official website, Zumax Medical Co., Ltd. was established in 2005. It is a manufacturer and service provider of surgical microscopes and clinical optical diagnostic instruments. The company is recognized as a National High-tech Enterprise, a National Gazelle Enterprise, a Jiangsu Province Private Science and Technology Enterprise, a Jiangsu Province Specialized, Fine, Unique and Innovative Little Giant Enterprise, and a Demonstration Enterprise for Achieving Industrialization at the Southern Jiangsu National Scientific and Technological Achievements Transfer and Transformation Demonstration Zone. Guided by its core values of "Technology-based, Innovation-driven, Customer-focused, Honest and Trustworthy," the company exports its products to over 120 countries and regions worldwide.

Zumax Medical focuses on the main theme of "microscopic, minimally invasive, and precise" in 21st-century clinical medicine, with the vision of "becoming the benchmark in China's microscopic medical equipment field." Dedicated to the clinical promotion of microscopic technology, Zumax has experienced and enjoyed the entire process of oral microscopic technology from its inception to fruition, establishing a leading position in China’s dental medicine niche market.

Zumax Medical Technology Center has been awarded the titles of "Jiangsu Provincial Engineering Research Center for 3D Dental Microscopes," "Suzhou Municipal Engineering Research Center for Medical Optics," "Outstanding R&D Institution in the High-Tech Zone," and "Graduate Workstation of the School of Optoelectronic Science and Engineering at Soochow University." It has obtained more than a hundred authorized invention and utility model patents, as well as PCT international patents. Zumax Medical products cover specialized clinical fields including dentistry, neurosurgery, otorhinolaryngology and head & neck surgery, microsurgery, ophthalmology, and gynecology.

According to the PharmaCube InvestGo investment and financing database, Zumax Medical completed a nearly 100-million-yuan Pre-IPO round of financing on August 13, 2022, with investors including SND Finance, Jiale Capital, and Yueyin Medical Fund.